The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis-Reference-Cited by-同舟云学术

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis

Published:2010-12-15 Issue:1 Volume:18 Page:69-77
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:

Author:

Devonshire V.,Lapierre Y.,Macdonell R.,Ramo-Tello C.,Patti F.,Fontoura P.,Suchet L.,Hyde R.,Balla I.,Frohman E. M.,Kieseier B. C.,

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1331.2010.03110.x/fullpdf

Reference27 articles.

1. Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence in treatment;Mohr;Mult Scler,1996

2. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis;Mohr;Arch Neurol,1997

3. Predictors of adherence to Copaxone therapy in individuals with relapsing-remitting multiple sclerosis;Fraser;J Neurosci Nurs,2001

4. Treatment adherence and patient retention in the first year of a phase-III clinical trial for the treatment of multiple sclerosis;Mohr;Mult Scler,1999

Cited by 287 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers and strategies to medication adherence amongst people with multiple sclerosis and cognitive problems;Multiple Sclerosis and Related Disorders;2024-08

2. Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registry;Journal of Central Nervous System Disease;2024-07-24

3. Navigating the discontinuation of multiple sclerosis first line treatments: A paradigm shift in patient care;Multiple Sclerosis and Related Disorders;2024-04

4. REBISTART: Adherence of Patients with Multiple Sclerosis to Treatment with Subcutaneous Interferon Beta in the Context of a Patient Support Program;Neurology and Therapy;2024-03-26

5. Treatment satisfaction with disease-modifying therapy is the only predictor of Adherence among multiple sclerosis patients from Upper Egypt;Scientific Reports;2024-03-25